Selective Antibodies
A dipstick for simply, rapidly and quantitatively monitoring patient compliance to protect against increasing TB drug resistance
- Funding £100,000
- Competition Medicines Management
- Competition Date Spring 2014
- Local AHSN North East & North Cumbria AHSN
- Website http://selectiveantibodies.com/
- Key Contact Prof Colin Self
- Status Proof of Concept
- Pathways Medicines Adherence
-
Technology In-vitro Diagnostics
Selective Antibodies is developing a rapid patient-side, dip stick testing system for TB drug adherence monitoring, allowing both patient and health care-worker to see at a glance, whether the correct level of medication has been taken. The new test is rapid, minimally-invasive, and critically – simple to perform and understand.
Comments are closed.